 |
Gene chip data improved therapy in some patients with incurable cancer
September 20, 2007ATLANTA - Like many oncologists, Eric P. Lester, M.D., was faced with a dilemma: seven patients with advanced, incurable cancer, an arsenal of drugs that may or may not help them, and not enough solid proof about treatment efficacy to guide him. So Dr. Lester devised what he called a "simple-minded experiment" that illustrates the promise of personalized medicine. Using DNA microarray "chips," Dr. Lester analyzed his patients' tumors for expression of genes associated with good response to various anti-cancer drugs, and based his drug treatment plans on the results. Four out of seven patients with advanced cancer enrolled in the extremely limited study had a better outcome than expected.
The finding, presented today in Atlanta, Ga. at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, shows that "a personalized molecular oncology approach, basing chemotherapy on relative gene expression in tumors, holds promise even at the relatively crude level employed here," said study investigator, Dr. Lester, president of Oncology Care Associates in St. Joseph, Mich.
To obtain and analyze chip data, Dr. Lester worked with Craig Webb, Ph.D., Director of Translational Medicine at the Van Andel Research Institute in Grand Rapids, Mich.
The study is unusual because oncologists don't yet base most of their treatment decisions on gene profiling, especially when it might involve pairing drugs together in a novel combination or using varied doses, Dr. Lester said. "Much of clinical medicine is an educated guess, and this was an attempt to come up with a better approach by using the technology of a gene chip to make multiple, highly educated guesses simultaneously," Dr. Lester said.
Dr. Lester added that one of the seven participating patients died before the gene chip was used to direct therapy.
Many current clinical trials involving gene expression examine effectiveness markers for individual drugs rather than combinations of drugs or different doses of agents used together for the first time. To truly help the most patients, Dr. Lester said, all potentially effective drugs and combinations must be matched up against the unique genetic profile of a patient's tumor, he said.
"Effective cancer treatment depends on understanding the biology driving the cancer, but because each tumor is different, it is very hard to personalize care and do a rigorous scientific experiment at the same time."
In this study, Dr. Lester said he "stayed within the envelope of a reasonable standard of care" in treating his patients. That standard is often based on what insurance companies will typically reimburse for treatment given published studies about the effectiveness of a drug on a certain tumor type, and whether or not the drug is federally approved for that indication. Dr. Lester and Webb surveyed the scientific literature and compiled a list of genes whose expression levels may predict response to a drug given the tumor type.
In some cases, treatment strategies suggested by the chips varied significantly even for the same type of cancer. For example, one patient whose lung cancer had spread to his brain and bones achieved a "near complete response" when treated with two chemotherapy drugs, in addition to Tarceva and Avastin, while another lung cancer patient responded to third-line drugs such as etoposide.
Acknowledging the risk involved with using novel combinations of drugs where no set safety profile exists, Dr. Lester said that "this is constantly done in medicine. People are taking antibiotics at the same time as using heart and cholesterol pills, and blood pressure medication."
"This kind of polypharmacy will become more common in cancer, but at the moment, it is hard to figure out the difference between doses that are effective or that could be toxic," he said.
The best way to get around such issues is to build a database of gene expression data and match them with patient outcomes, he said. "Now when I see new patients I am itching to look at what the genes can tell me," Dr. Lester said. "It is a smarter way to treat cancer."
American Association for Cancer Research
Related Cancer Current Events and Cancer News Articles
Drug reverses Alzheimer's disease deficits in mice, Pitt research confirms
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
UEA scientists make breast cancer advance that turns previous thinking on its head
UEA scientists make breast cancer advance that turns previous thinking on its head Scientists at the University of East Anglia have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function.
Scientists develop powerful new method for finding therapeutic antibodies
Scientists at The Scripps Research Institute (TSRI) have devised a powerful new technique for finding antibodies that have a desired biological effect. Antibodies, which can bind to billions of distinct targets, are already used in many of the world's best-selling medicines, diagnostics and laboratory reagents.
The world's favorite fruit only better-tasting and longer-lasting
Tomatoes, said to be the world's most popular fruit, can be made both better-tasting and longer-lasting thanks to UK research with purple GM varieties.
Future doctors unaware of their obesity bias
Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of Academic Medicine.
Protein preps cells to survive stress of cancer growth and chemotherapy
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
Improved chemo regimen for childhood leukemia may offer high survival, no added heart toxicity
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH).
Schools should provide students with daily physical activity, IOM recommends
A new report from the Institute of Medicine says schools should be responsible for helping pupils engage in at least 60 minutes of vigorous or moderate intensity activity during each school day.
Researchers find common childhood asthma unconnected to allergens or inflammation
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients.
Vaccine blackjack: IL-21 critical to fight against viral infections
Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
More Cancer Current Events and Cancer News Articles
 |
Anticancer, A New Way of Life, New Edition by David Servan-Schreiber MD PhD (Author) Anticancer has been a bestselling phenomenon since Viking first published it in fall 2008. Now, a new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it. The new edition of Anticancer includes: • The latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market • New information about how vitamin D strengthens the immune system • Warnings about common food contaminants that have recently been proven to contribute to cancer progression • A new chapter on mind-body approaches to stress reduction, with recent studies that show how our reactions to stress can interfere with... |
 |
The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee (Author) The Emperor of All Maladies is a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence. Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years. The story of cancer is a story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception. Mukherjee recounts centuries of... |
 |
The Cancer-Fighting Kitchen: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery by Rebecca Katz (Author), Mat Edelson (Author) A Culinary Pharmacy in Your Pantry The Cancer-Fighting Kitchen features 150 science-based, nutrient-rich recipes that are easy to prepare and designed to give patients a much-needed boost by stimulating appetite and addressing treatment side effects including fatigue, nausea, dehydration, mouth and throat soreness, tastebud changes, and weight loss. A step-by-step guide helps patients nutritionally prepare for all phases of treatment, and a full nutritional analysis accompanies each recipe. This remarkable resource teaches patients and caregivers how to use readily available powerhouse ingredients to build a symptom- and cancer-fighting culinary toolkit. Blending fantastic taste and meticulous science, these recipes for soups, vegetable dishes, proteins, and sweet and savory snacks... |
 |
Cancer: Step Outside the Box by Ty M. Bollinger (Author) Now in its 5th Edition (recently updated in 2011) and with over 100,000 copies sold since 2006, Cancer-Step Outside the Box is a “must-have” book that everyone should own. According to Dr. Rashid Buttar, author of The 9 Steps to Keep the Doctor Away, "Ty Bollinger's book, Cancer-Step Outside the Box, is an extraordinarily thorough and courageously well written book, brought to fruition by the dedication of a son for his departed parents. I found it difficult to put down this exceptional book once I began reading it and plan on recommending it to all my patients suffering from cancer who seek treatment at our clinic so that the light of truth and hope contained within this book can shine brightly on them as well." In the words of cancer survivor, Brad Matznick, “I am not a... |
 |
Cancer: 50 Essential Things to Do: 2013 Edition by Greg Anderson (Author) The ground-breaking classic guide to surviving cancer?now completely updated! Revised and updated for the first time since 1999, this invaluable guide to cancer recovery offers an easily accessible plan for patients and family members. Written by a cancer survivor, the book is an inspiring, action-oriented roadmap for those who choose to adopt a stance of hope and take charge of their diagnosis. With penetrating insights that bring together more than two decades of scientifically supported research and experience, Anderson reveals a step-by-step holistic action plan that has been successfully employed by hundreds of thousands of cancer patients worldwide. Anderson?s message is: ?You must not simply treat illness, you must also create wellness?physically, emotionally and... |
 |
"It's Cancer" by Jay Otterbacher (Author) Thirty-Two Weeks They Could Never Have Imagined - When your wife is diagnosed with cancer it is agonizing. When both of you are diagnosed within weeks of each other the uncertainty is relentless. Jay Otterbacher's memoir details one unbelievable year he could never have imagined. Anyone with a friend, colleague or loved one facing cancer can better understand what they are going through from this amazing story of thirty-two weeks in 2006. "It's Cancer" provides an unfiltered view behind the public facade into the home, relationships and treatment of one ordinary couple facing an inconceivable battle against two cancers at the same time. The implausible circumstances created the story. This narrative captures it in an open and friendly manner that allows you to be... |
 |
Cancer Is Not A Disease - It's A Survival Mechanism by Andreas Moritz (Author) In Cancer Is Not A Disease, bestselling author and internationally acclaimed health expert, Andreas Moritz, proves the point that cancer is the physical symptom reflecting our body's final attempt to eliminate specific life-destructive causes. He claims that removing such causes sets the precondition for complete healing of our body, mind and emotions. This book confronts you with a radically new understanding of cancer - one that outdates the current cancer model. On average, the conventional approaches of killing, cutting or burning cancerous cells offer most patients a remission rate of merely 7%, and the majority of the few survivors are "cured" for just five years or less. The prominent cancer researcher and professor at the University of California (Berkeley), Dr. Hardin Jones,... |
 |
Fight Now: Eat & Live Proactively Against Breast Cancer by Aaron Tabor, MD Dr. Tabor’s FIGHT NOW book provides information on lifestyle choices that might improve breast health and overall health. The purpose of Dr. Tabor’s medical research is to empower you to become proactive against breast cancer now with specific food and lifestyle choices. We can make specific food and lifestyle choices to lower the risk of getting breast cancer, risk of recurrence, and risk of dying from breast cancer. The only alternative is to be reactive after you get breast cancer or have a recurrence of breast cancer. The choice is clear Whether you are currently fighting breast cancer; are a survivor; or, simply trying to lower your risk, Dr. Tabor’s FIGHT NOW book will give you concise, critical information that you can start using today. You don’t have to read... |
 |
Cancer: 50 Essential Things to Do: Third Edition by Greg Anderson (Author) The ground-breaking classic guide to surviving cancer—now completely updated! Revised and updated for the first time since 1999, this invaluable guide to cancer recovery offers an easily accessible plan for patients and family members. Written by a cancer survivor, the book is an inspiring, action-oriented roadmap for those who choose to adopt a stance of hope and take charge of their diagnosis. With penetrating insights that bring together more than two decades of scientifically supported research and experience, Anderson reveals a step-by-step holistic action plan that has been successfully employed by hundreds of thousands of cancer patients worldwide. Anderson’s message is: “You must not simply treat illness, you must also create wellness—physically,... |
 |
Dying To Be Me: My Journey from Cancer, to Near Death, to True Healing by Anita Moorjani (Author) In this truly inspirational memoir, Anita Moorjani relates how, after fighting cancer for almost four years, her body—overwhelmed by the malignant cells spreading throughout her system—began shutting down. As her organs failed, she entered into an extraordinary near-death experience where she realized her inherent worth . . . and the actual cause of her disease. Upon regaining consciousness, Anita found that her condition had improved so rapidly that she was able to be released from the hospital within weeks . . . without a trace of cancer in her body! Within these pages, Anita recounts stories of her childhood in Hong Kong, her challenge to establish her career and find true love, as well as how she eventually ended up in that hospital bed where she defied all... |
| © 2013 BrightSurf.com |